Propofol Patent Expiration
Propofol is Used for preventing microbial growth, administering over a longer period, and inducing anesthesia. It was first introduced by Fresenius Kabi Usa Llc
Propofol Patents
Given below is the list of patents protecting Propofol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Diprivan | US5714520 | Propofol compostion containing edetate |
Mar 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan |
US5714520 (Pediatric) | Propofol compostion containing edetate |
Sep 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan | US5731355 | Pharmaceutical compositions of propofol and edetate |
Mar 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan |
US5731355 (Pediatric) | Pharmaceutical compositions of propofol and edetate |
Sep 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan | US5731356 | Pharmaceutical compositions of propofol and edetate |
Mar 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan |
US5731356 (Pediatric) | Pharmaceutical compositions of propofol and edetate |
Sep 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan | US5908869 | Propofol compositions containing edetate |
Mar 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan |
US5908869 (Pediatric) | Propofol compositions containing edetate |
Sep 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan | US8476010 | Propofol formulations with non-reactive container closures | Dec 01, 2024 | Fresenius Kabi Usa |
| Diprivan |
US8476010 (Pediatric) | Propofol formulations with non-reactive container closures | Jun 01, 2025 | Fresenius Kabi Usa |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Propofol Generics
Several generic applications have been filed for Propofol. The first generic version for Propofol was by Sagent Pharmaceuticals Inc and was approved on Jan 4, 1999. And the latest generic version is by Aspiro Pharma Ltd and was approved on Jun 20, 2024.
Given below is the list of companies who have filed for Propofol generic.
1. DR REDDYS
Dr Reddys Laboratories Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Prescription | INJECTION | AB | Nov 15, 2018 |
2. INNOPHARMA
Innopharma Licensing Llc A Sub Of Pfizer Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Innopharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Prescription | INJECTION | AB | Sep 16, 2020 |
3. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Prescription | INJECTION | AB | Apr 19, 2005 |
4. ASPIRO
Aspiro Pharma Ltd has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Aspiro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Prescription | INJECTION | AB | Jun 20, 2024 |
5. HOSPIRA
Hospira Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Prescription | INJECTION | AB | Mar 17, 2006 |
6. AVET LIFESCIENCES
Avet Lifesciences Ltd has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Avet Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Prescription | INJECTION | AB | Oct 12, 2021 |
7. SAGENT PHARMS INC
Sagent Pharmaceuticals Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Prescription | INJECTION | AB | Jan 4, 1999 |
8. TEVA PARENTERAL
Teva Parenteral Medicines Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Teva Parenteral.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Discontinued | INJECTION | N/A | Sep 19, 2000 |
9. WATSON LABS INC
Watson Laboratories Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Discontinued | INJECTION | N/A | Dec 22, 2015 |